Michael Sheppard

21 - 30 out of 101Page size: 10

Publications

  1. 2006
  2. Published

    Serum TSH concentration as a novel predictor of malignancy in thyroid nodules investigated by fine needle aspiration

    Kristien Boelaert, Roger Holder, Michael Sheppard & Jayne Franklyn, 5 Sep 2006, In: Journal of Clinical Endocrinology and Metabolism. 91, 11, p. 4295-4301 7 p.

    Research output: Contribution to journal › Article

  3. Published

    Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects

    Kristien Boelaert, Michael Sheppard, Roger Holder, Stephen Gough & Jayne Franklyn, 1 Feb 2006, In: Clinical Endocrinology. 64, 2, p. 125-128 4 p.

    Research output: Contribution to journal › Article

  4. Published

    Cardiac dysrhythmias in hyperthyroidism before and after antithyroid therapy

    Faizel Osman, Jayne Franklyn, Michael Sheppard & Michael Gammage, 1 Jan 2006, p. 215. 1 p.

    Research output: Contribution to conference (unpublished) › Abstract

  5. Published

    Growth hormone and its disorders

    John Ayuk & Michael Sheppard, 1 Jan 2006, In: Postgraduate Medical Journal. 82, 963, p. 24-30 7 p.

    Research output: Contribution to journal › Review article

  6. Published

    Poor outcome of atrial fibrillation associated with hyperthyroidism

    Faizel Osman, Jayne Franklyn, Michael Sheppard & Michael Gammage, 1 Jan 2006, p. 214. 1 p.

    Research output: Contribution to conference (unpublished) › Abstract

  7. 2005
  8. Published

    Consensus statement: medical management of acromegaly

    Michael Sheppard, 1 Dec 2005, In: European Journal of Endocrinology. 153(6), p. 737-740 4 p.

    Research output: Contribution to journal › Article

  9. Published

    Thyroid function and mortality in patients treated for hyperthyroidism

    Jayne Franklyn, Michael Sheppard, 6 Jul 2005, In: JAMA The Journal of the American Medical Association. 294, 1, p. 71-80 10 p.

    Research output: Contribution to journal › Article

  10. Published

    Long-acting octreotide and prolonged-release lanreotide formulations have different pharmacokinetic profiles

    Michael Sheppard, 1 Jul 2005, In: Journal of Clinical Pharmacology. 45(7), p. 836-844 9 p.

    Research output: Contribution to journal › Article

  11. Published

    Letter re: Monitoring the Response to Treatment in Acromegaly

    John Ayuk, Michael Sheppard, Andrew Bates & Paul Stewart, 10 May 2005, In: Journal of Clinical Endocrinology and Metabolism. 90, 8, p. 4980-4980 1 p.

    Research output: Contribution to journal › Letter

  12. Published

    Association between serum TSH and free T4 concentrations and occurrence of atrial fibrillation in a large community-based population of elderly subjects. The Birmingham Elderly Thyroid Study

    Michael Gammage, Jim Parle, Jayne Franklyn, Sue Wilson, Roger Holder, Michael Sheppard, Andrea Roalfe, 1 Jan 2005, p. OC34.

    Research output: Contribution to conference (unpublished) › Abstract

Previous 1 2 3 4 5 6 7 8 ...11 Next